Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
107,473 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
683,701 views
1 reaction
Last Post ECO
by ECO
 
Started by Pol2021, 07-20-2022, 06:53 AM
0 responses
158 views
0 reactions
Last Post Pol2021
by Pol2021
 
Started by onca, 07-13-2022, 06:43 AM
0 responses
207 views
0 reactions
Last Post onca
by onca
 
Started by ecSeq Bioinformatics, 07-04-2022, 11:26 PM
0 responses
370 views
0 reactions
Last Post ecSeq Bioinformatics  
Started by ecSeq Bioinformatics, 05-31-2022, 02:24 AM
3 responses
180 views
0 reactions
Last Post ecSeq Bioinformatics  
Started by colinhercus, 06-21-2022, 04:07 AM
2 responses
205 views
0 reactions
Last Post colinhercus  
Started by ecSeq Bioinformatics, 06-28-2022, 01:03 AM
0 responses
234 views
0 reactions
Last Post ecSeq Bioinformatics  
Started by metheuse, 06-20-2022, 08:26 AM
0 responses
253 views
0 reactions
Last Post metheuse  
Started by metheuse, 06-20-2022, 08:21 AM
0 responses
200 views
0 reactions
Last Post metheuse  
Started by szy0931, 06-19-2022, 06:03 AM
0 responses
104 views
0 reactions
Last Post szy0931
by szy0931
 
Started by Bowser86, 06-13-2022, 12:57 AM
0 responses
155 views
0 reactions
Last Post Bowser86  
No topics found.
  • Filter
  • Time
Clear All
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.

Recent Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Working...